Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: Assessment by increase in myocardial I-123-metaiodobenzylguanidine uptake
U. Lotze et al., Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: Assessment by increase in myocardial I-123-metaiodobenzylguanidine uptake, J NUCL MED, 42(1), 2001, pp. 49-54
Citations number
39
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
In chronic heart failure, elevated plasma norepinephrine (NE) levels and a
disparity between the neuronal release and the effective reuptake of NE lea
d to an increased concentration of NE in the presynaptic cleft, causing a d
ownregulation of the myocardial beta -adrenoceptors. The clinical and progn
ostic effectiveness of beta -blocker therapy has been shown in patients wit
h chronic heart failure in several large trials. The purpose of this study
was to investigate the effect of long-term beta -blocker therapy on the car
diac adrenergic nervous system as assessed by the myocardial uptake of I-12
3-metaiodobenzylguanidine (MIBG), an analog of NE, in idiopathic dilated ca
rdiomyopathy (IDC). Methods: in 10 patients with [DC and stable chronic hea
rt failure the myocardial MIBG uptake was measured at baseline and at 1 y (
median, 11.5 mo) after treatment with beta -blockers (metoprolol, n = 5; bi
soprolol, n = 1; and carvedilol, n = 4) in addition to standard medication.
In parallel with the changes in MIBG uptake, the New York Heart Associatio
n functional class, the left ventricular ejection fraction (LVEF), and the
left ventricular end-diastolic diameter (LVEDD) were documented before and
after 1 y of therapy with beta -blockers. Results: During the 1-y follow-up
, a significant increase in myocardial I-123-MIBG uptake (P = 0.005) in par
allel with an improved LVEF (P = 0.005) and a reduced LVEDD (P = 0.019) was
found. A trend toward an improvement of the New York Heart Association fun
ctional class under the beta -blocker therapy (P = 0.139) was also found. C
onclusion: Assessment of the myocardial I-123-MIBG uptake is a useful nonin
vasive tool for evaluating changes in cardiac sympathetic nerve activity un
der medical therapy. Long-term treatment with beta -blockers in IDC causes
a recovery of the cardiac adrenergic nervous system concomitantly with a cl
inical and hemodynamic improvement.